PerkinElmer | 01-May-2021
| Technical / White Paper
The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...
We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...
Telstar Life Science Solutions | 30-Sep-2019
| Case Study
A new vacuum induced nucleation method in the freeze-drying process, Telstar Lyonuc, reduces the duration of the primary drying cycle and ensures the homogenization...
Catalent Pharma Solutions | 22-Oct-2018
| Technical / White Paper
Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...
From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...
Catalent Pharma Solutions | 05-Mar-2018
| Technical / White Paper
Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...
Steridose, Inc | 14-Sep-2017
| Technical / White Paper
The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...
The latest development of the GELITA Competence Team is GELITA® RXL R2 that takes the reduced cross-linking (RXL) concept provided by GELITA® RXL one step...
Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....
